21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Method for Modulating Epithelial Stem Cell Lineage
#6902Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapy
#6903Herbal formulation advocated for the prevention and management of coronary heart disease
#6904Role of an herbal formulation in the prevention and management of age related neurodegenerative disorders with special reference to senile dementia
#6905Compositions and methods for promoting weight loss and increasing energy
#6906Skin penetration composition
#6907Antimicrobial hydrochloric acid catheter lock solution and method of use
#6908Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
#69094-ISOPROPYL-3-METHYLPHENOL FOR THE TREATMENT OF INFLAMMATION
#6910Nutraceutical for the prevention and treatment of cancers and diseases affecting the liver
#6911TRANSDERMAL DELIVERY OF CANNABINOIDS
#6912Oral compositions comprising a zinc compound and an anti-microbial agent
#6913Resuscitation fluid
#6914Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic
#6915Bacterial ghosts for mediating innate immunity
#6916Elastase inhibitor
#6917Methods of treating secondary bone tumors with antibodies against PDGFR alpha
#6918Method of Administering an Antibody
#6919CYTOKINE-EXPRESSING CELLULAR VACCINE COMBINATIONS
#6920Compositions and methods for treating hepatitis virus infection
#6921RBM3 in colorectal cancer prognostics
#6922Anti-neoplastic compositions comprising extracts of black cohosh
#6923METHODS AND KITS FOR DETERMINING THE PROGNOSIS OF PULMONARY SARCOIDOSIS
#6924Treatment with anti-ErbB2 antibodies
#6925PKC activators and anticoagulant in regimen for treating stroke
#6926Composition for regulating lipid metabolism
#6927Formulations including digestive enzymes, polysorbate-based surfactants and probiotics
#6928CARRIERS FOR STORAGE AND DELIVERY OF BIOLOGICS
#6929EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION
#6930Hepatitis C Inhibitor Compounds
#69314'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
#6932METHOD OF WHITENING SKIN
#6933Compositions And Methods For Reducing Appearance Of Under-Eye Dark Circles
#6934Drug Combinations Useful for Prevention of Restenosis
#6935Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with Hsp60sp peptide
#6936Drug releasing coatings for medical devices
#6937COMPOSITION AND METHOD FOR PHOTODYNAMIC DISINFECTION
#6938Systems and methods for delivery of a therapeutic agent
#6939PROCESS FOR (3R, 5R)-7-[2-(4-FLUOROPHENYL)-5-ISOPROPYL-3-PHENYL-4- [(4-HYDROXY METHYL PHENYL AMINO) CARBONYL]-PYRROL-1-YL]-3, 5-DIHYDROXY-HEPTANOIC ACID HEMI CALCIUM SALT
#6940ANTI-ANXIETY COMPOSITION
#6941Compositions and Method for Temporary Reduction of Nasal and Sinus Pain
#6942STABILIZATION OF QUINOL COMPOSITION SUCH AS CATECHOLAMINE DRUGS
#6943NUTRITIONAL OR THERAPEUTIC COMPOSITIONS TO INCREASE BODILY GLUTATHIONE LEVELS
#6944Pharmaceutical compositions having desirable bioavailability
#6945USE OF FLAVONES FOR TREATING PSYCHIATRIC DISORDERS WITH SENSORIMOTOR GATING DEFICITS
#6946PHARMACEUTICAL COMPOSITIONS COMPRISING PYRIDYL CYANOGUANIDINE, PROCESS FOR PREPARING THE SAME AND USE THEREOF
#6947Spot-on pesticide composition
#6948METADOXINE FOR USE AS INHIBITOR OF HEPATIC FIBROSIS
#6949Compositions and methods for treating hyperlipidemias
#6950Spot-on pesticide composition
#6951Spot-on pesticide composition
#6952Nitrogen-containing heteroaryl compounds and methods of use thereof
#6953Co-crystal of etravirine and nicotinamide
#6954Compounds effective against cancer
#6955Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals
#6956PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS
#6957COMBINATIONAL THERAPY FOR TREATING AUTOIMMUNE DISEASE
#6958Pharmaceutical combination
#6959Medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
#6960Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
#6961Drug combinations containing PDE4 inhibitors and NSAIDs
#6962Phosphate management with small molecules
#6963PHARMACEUTICAL COMPOSITION COMPRISING A PROTON PUMP INHIBITOR AND A PREBIOTIC FOR THE TREATMENT OF ULCEROUS LESIONS OF THE STOMACH AND DUODENUM
#6964Methods of modulating bromodomains
#6965Mucin derived polypeptides
#6966STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS
#6967Methods for treatment of headaches by administration of oxytocin
#6968HIGHLY SENSITIVE DETECTION METHOD FOR HIGHLY VIRULENT ORAL CAVITY BACTERIA
#6969Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
#6970Resuscitation fluid
#6971Immunopotentiating fermented food obtained from fructan-containing food
#6972CONSUMABLE DISSOLVING FILM COMPRISING ACTIVE INGREDIENTS DERIVED FROM BACTERIA AND FUNGI
#6973Composition and Method for the Topical Treatment of Dermatitis
#6974Compositions for treatment of skin and ear infections
#6975Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system
#6976Azelaic acid-comprising formulation with added pigment
#6977PHARMACEUTICAL COMPOSITION COMPRISING EZETIMIBE AND SIMVASTATIN
#6978Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
#6979Stable pharmaceutical composition for atherosclerosis
#6980Enzyme delivery systems and methods of preparation and use
#6981Anti-viral azide containing compounds
#6982DENTIN MINERALIZING AGENT AND METHOD FOR PRODUCTION THEREOF
#6983Dose selection of adjuvanted synthetic nanocarriers
#6984Chimera comprising bacterial cytotoxin and methods of using the same
#6985Antibodies against PDGFRα to inhibit tumor growth
#6986ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
#6987Compositions and methods for treating cancer
#6988Immunological reconstitution promoter or prophylactic agent for infections each of which maintains graft-versus-tumor effect
#6989MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#6990Method and means for producing tissues and tissues obtained
#6991Adjunctive agent for lavaging the alimentary canal comprising butyric acid bacterium and/or lactic acid bacterium
#6992TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION
#6993HEPATITIS C VIRUS COMBINATION THERAPY
#6994COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#6995Povidone Iodine, A Novel Alternative Preservative For Ophthalmic Compositions
#6996Canna and Shea topical cream
#6997Skin care compositions comprising substituted monoamines
#6998METHODS AND COMPOSITIONS FOR PREVENTING AND RELIEVING MUSCLE CRAMPS AND FOR RECOVERY FROM NEUROMUSCULAR IRRITABILITY AND FATIGUE FOLLOWING EXERCISE
#6999FATTY ACID PROTEIN KINASE C ACTIVATORS AND ANTICOAGULANT FOR THE TREATMENT OF STROKE
#7000Cancer therapy based on tumor associated antigens derived from cyclin D1
#7001IL-18 RECEPTOR AS A NOVEL TARGET OF REGULATORY T CELLS IN CANCER
#7002Multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
#7003Transdermal compositions
#7004Solid-forming local anesthetic formulations for pain control
#7005Anti-constipation composition
#7006Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel
#7007PHD2 inhibition for blood vessel normalization, and uses thereof
#7008Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
#7009TREATMENT AND PREVENTION OF DELETERIOUS EFFECTS ASSOCIATED WITH ALCOHOL CONSUMPTION
#7010Spot-on pesticide composition
#7011Compound for the treatment of enteroviruses
#7012Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction
#7013Thienopyridine derivatives for the treatment and prevention of dengue virus infections
#7014ANIMAL TREATMENT FORMULATION AND METHODS OF USE
#7015METHODS FOR REDUCING OR NEOVASCULARIZATION OR EDEMA
#7016SGC STIMULATORS OR SGC ACTIVATORS IN COMBINATION WITH PDE5 INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
#7017METHOD OF TREATING CANCER
#7018Medicinal Steroids Cream And A Process To Make It
#7019ANTI-VIRAL PROPERTIES OF ALOE VERA AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) TREATMENT
#7020METHOD OF TREATMENT AND SUPPLEMENT
#7021Use of flavonoids to increase the bioavailability of hesperetin
#7022METHOD AND COMPOSITION FOR MODULATING CANONICAL WNT PATHWAY USING FOLATE AND INOSITOL
#7023Treatment of T-cell mediated diseases
#7024Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#7025USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY
#7026Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#7027PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
#7028Combination of an insulin and a GLP-1-agonist
#7029Promotion of healthy catch-up growth
#7030Methods for treating interstitial cystitis
#7031GROWTH FACTOR HOMOLOG ZVEGF4
#7032Garcinia Mangostana L. and Iridoid Based Formulations
#7033SYNERGISTIC HERBAL COMPOSITION FOR TREATMENT OF RHEUMATIC AND MUSCULO-SKELETAL DISORDERS (RMSDS)
#7034P2X3, receptor antagonists for treatment of pain
#7035Systemic administration of NAC as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with DHEA for the treatment of smallpox
#7036Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis
#7037MAINTENANCE FLUID FOR ANIMALS
#7038MEDICAL AND NUTRITIONAL FORMULATIONS
#7039Single daily dosage form for prevention and treatment of metabolic syndrome
#7040Methods for inhibiting cancer cell proliferation
#7041Contraceptive transdermal delivery of hormones
#7042COMPOSITE NANOSTRUCTURES AND METHODS FOR MAKING AND USING THEM
#7043CORROSION CURRENT-GENERATING METAL PARTICULATES AND USE THEREOF
#7044NOVEL PHARMACEUTICAL USES FOR NANOPARTICLES
#7045ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING EXTRACTS FROM BROUSSONETIA PAPYRIFERA AND LONICERA JAPONICA
#7046ANTIPLATELET AGENT AND METHODS OF USING THE SAME
#7047METHODS OF TREATING COLORECTAL CANCER
#7048EMP2 ANTIBODIES AND THEIR THERAPEUTIC USES
#7049Formulations and treatments for trichology
#7050Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#7051Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#7052Method of treating lupus nephritis
#7053Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
#7054DAG-TYPE AND INDIRECT PROTEIN KINASE C ACTIVATORS AND ANTICOAGULANT FOR THE TREATMENT OF STROKE
#7055COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE
#7056Food Supplement and Method for Enhancing Athletic Performance
#7057Pharmaceutical, dermatological, nutritional or cosmetic composition for combating the immunosuppresive action of aggressive agents on the skin
#7058Methods and compositions for detection of bacteria and treatment of diseases and disorders
#7059Treatment of Comorbid Premature Ejaculation and Erectile Dysfunction
#7060Reducing Side Effects of Tramadol
#7061Use of salt of an acetylsalicylic acid for the treatment of viral infections
#7062Seroma Control for Surgical Patients
#7063Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
#7064Combination of selected opioids with muscarine antagonists for treating urinary incontinence
#7065RNAi molecule targeting thymidylate synthase and application thereof
#7066Succinimide derivatives as ocular hypotensive agents
#7067METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGY
#7068COMPOSITION AND METHOD OF DECREASING RENAL ISCHEMIC DAMAGE
#7069Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability
#7070Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (COPD)
#7071Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
#7072THERAPIES FOR TREATING CANCER USING COMBINATIONS OF COX-2 INHIBITORS AND AROMATASE INHIBITORS OR COMBINATIONS OF COX-2 INHIBITORS AND ESTROGEN RECEPTOR ANTAGONISTS
#7073Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy
#7074METHODS AND PREPARATIONS FOR PROTECTING CRITICALLY ILL PATIENTS
#7075Unitary combinations of FSH and hCG
#7076Plant extracts composition for the treatment of liver dysfunction-jaundice
#7077Composition for prevention or treatment of insomnia
#7078COMPOSITION COMPRISING EXTRACTS OR FRACTIONS OF SPECIFIC PLANTS, USE THEREOF AND PROCESS FOR PREPARING THE EXTRACTS
#7079COMPOSITION AND METHOD FOR CONTROLLING THE RESPIRATORY EFFECTS OF INHALED POLLUTANTS AND ALLERGENS
#7080P2Xreceptor antagonists for treatment of pain
#7081Choline-silicic acid complex with osmolytes and divalent trace elements
#7082Traditional Chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof
#7083COMBINATION PREPARATION COMPRISING INHIBITOR OF HMG-COA REDUCTASE AND ASPIRIN AND METHOD FOR MANUFACTURING THE SAME
#7084NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#7085CHOLESTANOL DERIVATIVE FOR COMBINED USE
#7086ANTI-APPETITE ADHESIVE COMPOSITIONS
#7087Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#7088Therapeutic Compositions for Treatment of Corneal Disorders
#7089COMPOSITIONS AND METHODS OF TREATING TUMORS
#7090Probiotics, secretory IgA and infection
#7091Methods for treating inflammatory bowel disease
#7092Enhanced Natural Colors
#7093Hypoglycemic effect enhancer
#7094Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
#7095METHODS OF TREATING HIV PATIENTS WITH ANTI-FIBROTICS
#7096Estriol Therapy for Autoimmune and Neurodegenerative Disease and Disorders
#7097Process for preparing antiviral compounds
#7098Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor
#7099USE OF SUBSTITUTED CYANOPYRROLIDINES AND COMBINATION PREPARATIONS CONTAINING THEM FOR TREATING HYPERLIPIDEMIA AND ASSOCIATED DISEASES
#7100TABLET FORMULATION
#7101Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF)
#7102Swallowable drug delivery device and method of delivery
#7103Angiogenesis initiation and growth
#7104Photosensitizing antibody-fluorophore conjugates
#7105USE OF NANOPARTICLES FOR THE TREATMENT OF CANCER
#7106Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
#7107DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERS
#7108Method for placental exfoliation using oxo-arachidonic acid or the like
#7109Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
#7110AVERMECTIN COMPOUNDS AND TREATMENT OF DERMATOLOGICAL DISORDERS IN HUMANS THEREWITH
#7111Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D
#7112NOVEL MEDICAMENT FOR TREATING COGNITIVE IMPAIRMENT
#71135-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF
#7114Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof
#7115METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE
#7116COMPOSITIONS FOR AFFECTING WEIGHT LOSS
#7117METHODS AND COMPOSITIONS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCERS ASSOCIATED WITH HEDGEHOG SIGNALING
#7118THERAPEUTIC REGIMENS FOR HEDGEHOG-ASSOCIATED CANCERS
#7119Pharmaceutical composition
#7120Pharmaceutical composition for treatment of type 2 diabetes
#7121Chemical compounds
#7122MicroRNA Modulators and Method for Identifying And Using The Same
#7123COMBINATION THERAPIES WITH COX-2 INHIBITORS AND TREPROSTINIL
#7124Method of stimulating the motility of the gastrointestinal system using ipamorelin
#7125COMBINATION THERAPIES USING NAP
#7126Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof
#7127Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
#7128Methods for treating progressive cognitive disorders related to neurofibrillary tangles
#7129Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same
#7130Use of extracts and their compounds on inhibition of xanthine oxidase
#7131Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
#7132Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
#7133Plant extracts for treating skin disorders and enhancing healing of wounds for diabetic patients
#7134Composition to retard the onset of symptoms of alzheimer's disease
#7135METHOD FOR SELECTION OF NOVEL ANTI-CANCER HERBS USING CHEMINFORMATIC TOOLS
#7136Composition for the treatment of oxidative stress
#7137Kit of pharmaceutical formulations characterized by the presence of molecular oxygen
#7138Compositions and methods for creating an air release mechanism to maintain skin health
#7139METHOD OF DISEASE-INDUCED AND RECEPTOR-MEDIATED STEM CELL NEUROPROTECTION
#7140NOVEL GASTRO-RETENTIVE DOSAGE FORMS
#7141FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
#7142Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren
#7143Treatment including prebiotic composition for use with probiotics
#7144Liposomal formulations of anthracycline agents and cytidine analogs
#7145CHOLESTANOL DERIVATIVE FOR COMBINED USE
#7146Administration of growth factors for the treatment of CNS disorders
#7147Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity
#7148Wound healing compositions containing keratin biomaterials
#7149Prebiotic compositions for use with probiotics to increase probiotic growth rate and activity
#7150ACTIVE COATING OF PHARMACEUTICAL DOSAGE FORMS
#7151COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES
#7152Depletion of cancer stem cells
#7153Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#7154INTRAVENOUS AND ORAL DOSING OF A DIRECT-ACTING AND REVERSIBLE P2Y12 INHIBITOR
#7155Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition
#7156Prebiotic composition for increasing probiotic growth rate and activity
#7157Increasing probiotic growth rate and activity using prebiotic composition
#7158Treatment of Fibrosis related disorders
#7159Compostition and therapeutic anti-tumour vaccine
#7160APOE4 AND APOJ BIOMARKER-BASED PREVENTION AND TREATMENT OF DEMENTIA
#7161BUFFERED COMPOSITIONS FOR DIALYSIS
#7162Feminine fresh all day
#7163Antibodies to insulin-like growth factor I receptor
#7164METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / CALCIUM CHANNEL BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION
#7165Gas mist pressure bath device
#7166Composition for solubilizing tissue comprising 3-(decyl dimethyl ammonio) propane sulfonate and tetraethylene glycol dodecyl ether
#7167Use Of Serine Protease Inhibitors In The Treatment Of Neutropenia
#7168Method for treating ocular demodex
#7169Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
#7170EXTERNAL PREPARATION CONTAINING ANALGESIC/ANTI-INFLAMMATORY AGENT
#7171EXTERNAL PREPARATION CONTAINING ANALGESIC/ANTI-INFLAMMATORY AGENT
#7172Agent for alleviating vascular failure
#7173ANTITUMOR COMBINATION COMBINING AVE8062 AND DOCETAXEL
#7174ERBB-3 (HER3)-SELECTIVE COMBINATION THERAPY
#7175PDK inhibitor compounds and methods of use thereof
#7176Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
#7177Substituted triazolo-pyridazine derivatives
#7178USE OF RANOLAZINE FOR TREATING PULMONARY HYPERTENSION
#7179PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INDUCTION AND ENHANCEMENT OF APOPTOSIS IN TUMOR CELLS
#7180Compositions and methods of delivery of pharmacological agents
#7181Inhibitors of NF-κB activity
#7182EXENDINS AND EXENDIN AGONIST ANALOGS TO REGULATE GASTROINTESTINAL MOTILITY
#7183HYDROXYPROLINE COMPOSITIONS AND USES THEREOF
#7184Dietary supplement
#7185Nutraceutical product containing anatabine and yerba maté
#7186COMPOSITIONS AND METHODS FOR DETOXIFICATION AND CANCER PREVENTION
#7187COMPOSITIONS AND METHODS FOR CONTROLLING BLOOD GLUCOSE LEVELS
#7188HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF
#7189Method of removing ticks from the skin and reducing the risk of bites
#7190METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE
#7191USE OF HELIUM-OXYGEN GAS MIXTURES FOR TREATING PULMONARY ARTERIAL HYPERTENSION
#7192EYE DROPS CONTAINING A DEPROTEINIZED CALF BLOOD EXTRACT
#7193Multilayer Minitablets with Different Release Rates
#7194Pharmaceutical Composition Comprising Aliskiren
#7195Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss
#7196COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA
#7197NEW METHODS OF TREATING DRY EYE SYNDROME
#7198NITRIC OXIDE-RELEASING DRESSINGS
#7199Anti-inflammatory dissolvable film
#7200Method for reducing pain